149 related articles for article (PubMed ID: 37937948)
1. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.
Min H; Yang L; Xu X; Geng Y; Liu F; Liu Y
Cell Cycle; 2023 Oct; 22(19):2130-2141. PubMed ID: 37937948
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
[TBL] [Abstract][Full Text] [Related]
5. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells.
Shi Y; Sun L; Zhang R; Hu Y; Wu Y; Dong X; Dong D; Chen C; Geng Z; Li E; Fan Y
J Exp Clin Cancer Res; 2021 Jan; 40(1):14. PubMed ID: 33407730
[TBL] [Abstract][Full Text] [Related]
7. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
Golob-Schwarzl N; Wodlej C; Kleinegger F; Gogg-Kamerer M; Birkl-Toeglhofer AM; Petzold J; Aigelsreiter A; Thalhammer M; Park YN; Haybaeck J
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2699-2711. PubMed ID: 31586263
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F
Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
[TBL] [Abstract][Full Text] [Related]
12. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-197 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by targeting insulin-like growth factor-binding protein 3.
Tong L; Cheng J; Zuo H; Li J
Adv Clin Exp Med; 2021 Jul; 30(7):661-672. PubMed ID: 34118139
[TBL] [Abstract][Full Text] [Related]
14. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma.
He Y; Chen X; Yu Y; Li J; Hu Q; Xue C; Chen J; Shen S; Luo Y; Ren F; Li C; Bao J; Yan J; Qian G; Ren Z; Sun R; Cui G
Mol Carcinog; 2018 Jun; 57(6):772-783. PubMed ID: 29569755
[TBL] [Abstract][Full Text] [Related]
15. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
[TBL] [Abstract][Full Text] [Related]
16. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
[TBL] [Abstract][Full Text] [Related]
17. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
18. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma.
Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB
Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway.
Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y
Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer.
Chen J; Yu Y; Li H; Hu Q; Chen X; He Y; Xue C; Ren F; Ren Z; Li J; Liu L; Duan Z; Cui G; Sun R
Mol Cancer; 2019 Mar; 18(1):33. PubMed ID: 30825877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
